Search

Your search keyword '"Greene M.H."' showing total 155 results

Search Constraints

Start Over You searched for: Author "Greene M.H." Remove constraint Author: "Greene M.H."
155 results on '"Greene M.H."'

Search Results

1. Genome-wide Association Study of Bladder Cancer Reveals New Biological and Translational Insights.

2. Polygenic risk modeling for prediction of epithelial ovarian cancer risk

3. Association Study between Polymorphisms in DNA Methylation-Related Genes and Testicular Germ Cell Tumor Risk

5. Height and Body Mass Index as Modifiers of Breast Cancer Risk in BRCA1/2 Mutation Carriers: A Mendelian Randomization Study

6. A case-only study to identify genetic modifiers of breast cancer risk for BRCA1/BRCA2 mutation carriers

7. A case-only study to identify genetic modifiers of breast cancer risk for BRCA1/BRCA2 mutation carriers

8. Author Correction: A case-only study to identify genetic modifiers of breast cancer risk for BRCA1/BRCA2 mutation carriers (Nature Communications, (2021), 12, 1, (1078), 10.1038/s41467-020-20496-3).

9. Erratum: Author Correction: A case-only study to identify genetic modifiers of breast cancer risk for BRCA1/BRCA2 mutation carriers (Nature communications (2021) 12 1 (1078)).

10. Polygenic risk scores and breast and epithelial ovarian cancer risks for carriers of BRCA1 and BRCA2 pathogenic variants.

11. A case-only study to identify genetic modifiers of breast cancer risk for BRCA1/BRCA2 mutation carriers.

12. Characterization of the Cancer Spectrum in Men with Germline BRCA1 and BRCA2 Pathogenic Variants: Results from the Consortium of Investigators of Modifiers of BRCA1/2 (CIMBA).

13. Breast and Prostate Cancer Risks for Male BRCA1 and BRCA2 Pathogenic Variant Carriers Using Polygenic Risk Scores.

14. Genome-wide association study identifies 32 novel breast cancer susceptibility loci from overall and subtype-specific analyses

15. Fine-mapping of 150 breast cancer risk regions identifies 191 likely target genes

16. Association of Genomic Domains in BRCA1 and BRCA2 with Prostate Cancer Risk and Aggressiveness

17. Polygenic risk scores and breast and epithelial ovarian cancer risks for carriers of BRCA1 and BRCA2 pathogenic variants

18. Association of genomic domains in BRCA1 and BRCA2 with prostate cancer risk and aggressiveness.

19. Assessment of polygenic architecture and risk prediction based on common variants across fourteen cancers.

20. Fine-mapping of 150 breast cancer risk regions identifies 191 likely target genes.

21. Transcriptome-wide association study of breast cancer risk by estrogen-receptor status.

22. Genome-wide association study identifies 32 novel breast cancer susceptibility loci from overall and subtype-specific analyses.

23. Transcriptome-wide association study of breast cancer risk by estrogen-receptor status

24. Shared heritability and functional enrichment across six solid cancers (vol 10, 431, 2019)

25. Mendelian randomisation study of height and body mass index as modifiers of ovarian cancer risk in 22,588 BRCA1 and BRCA2 mutation carriers

26. The FANCM:p.Arg658* truncating variant is associated with risk of triple-negative breast cancer.

27. Shared heritability and functional enrichment across six solid cancers.

28. Publisher Correction: Shared heritability and functional enrichment across six solid cancers (Nature Communications, (2019), 10, 1, (431), 10.1038/s41467-018-08054-4).

29. Genome-wide association and transcriptome studies identify target genes and risk loci for breast cancer.

30. Erratum: Publisher Correction: Shared heritability and functional enrichment across six solid cancers (Nature communications (2019) 10 1 (431))

32. A twofold increase in BRCA mutation related prostate cancer among Ashkenazi Israelis is not associated with distinctive histopathology

33. Family history of breast cancer as a determinant of the risk of developing endometrial cancer: a nationwide cohort study. (Letter to JMG)

35. Mutational spectrum in a worldwide study of 29,700 families with BRCA1 or BRCA2 mutations

36. Prediction of Breast and Prostate Cancer Risks in Male BRCA1 and BRCA2 Mutation Carriers Using Polygenic Risk Scores

37. Meta-analysis of five genome-wide association studies identifies multiple new loci associated with testicular germ cell tumor

38. Association of breast cancer risk in BRCA1 and BRCA2 mutation carriers with genetic variants showing differential allelic expression: identification of a modifier of breast cancer risk at locus 11q22.3

39. Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer

40. BRCA2 polymorphic stop codon K3326X and the risk of breast, prostate, and ovarian cancers

41. A Nonsynonymous Polymorphism in IRS1 Modifies Risk of Developing Breast and Ovarian Cancers in BRCA1 and Ovarian Cancer in BRCA2 Mutation Carriers

42. Assessing Associations between the AURKA-HMMR-TPX2-TUBG1 Functional Module and Breast Cancer Risk in BRCA1/2 Mutation Carriers

43. Identification of independent association signals and putative functional variants for breast cancer risk through fine-scale mapping of the 12p11 locus

44. Functional mechanisms underlying pleiotropic risk alleles at the 19p13.1 breast-ovarian cancer susceptibility locus

45. BRCA2 Polymorphic Stop Codon K3326X and the Risk of Breast, Prostate, and Ovarian Cancers

46. Association of breast cancer risk in BRCA1 and BRCA2 mutation carriers with genetic variants showing differential allelic expression: identification of a modifier of breast cancer risk at locus 11q22.3

47. Inheritance of deleterious mutations at both BRCA1 and BRCA2 in an international sample of 32,295 women

48. Identification of independent association signals and putative functional variants for breast cancer risk through fine-scale mapping of the 12p11 locus

49. Identification of four novel susceptibility loci for oestrogen receptor negative breast cancer

50. No clinical utility of KRAS variant rs61764370 for ovarian or breast cancer

Catalog

Books, media, physical & digital resources